Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2069
Título: Minimally invasive interventions for biopsy of malignancy suspected pulmonary nodules: a systematic review and meta-analysis
Autor(es): Miotto, André
Perfeito, João Aléssio Juliano Perfeito
Pacheco, Rafael Leite
Latorraca, Carolina de Oliveira Cruz
Riera, Rachel
Palavras-chave: Neoplasias pulmonares
Revisão sistemática
Data do documento: 2023
Editor: Associação Paulista de Medicina - APM
Citação: Miotto, André, et al. “Minimally invasive interventions for biopsy of malignancy-suspected pulmonary nodules: a systematic review and meta-analysis”. Sao Paulo Medical Journal, vol. 141, no 5, 2023, p. e2022543. DOI.org (Crossref), https://doi.org/10.1590/1516-3180.2022.0543.r1.01022023.
Resumo: BACKGROUND: Imaging tests are important for diagnosis during the management of pulmonary nod ules; however, biopsy is required to confirm the malignancy. OBJECTIVES: To compare the effects of different techniques used for the biopsy of a pulmonary nodule. DESIGN AND SETTING: Systematic review and meta-analysis were conducted using Cochrane method ology in São Paulo, São Paulo, Brazil. METHODS: We conducted a systematic review of randomized controlled trials (RCTs) on minimally inva sive techniques, including tomography-guided percutaneous biopsy (PERCUT), transbronchial biopsies with fluoroscopy (FLUOR), endobronchial ultrasound (EBUSR), and electromagnetic navigation (NAVIG). The primary outcomes were diagnostic yield, major adverse events, and need for another approach. RESULTS: Seven RCTs were included (913 participants; 39.2% female, mean age: 59.28 years). Little to no increase was observed in PERCUT over FLUOR (P = 0.84), PERCUT over EBUSR (P = 0.32), and EBUSR over NAVIG (P = 0.17), whereas a slight increase was observed in NAVIG over FLUOR (P = 0.17); however, the evidence was uncertain. EBUSR may increase the diagnostic yield over FLUOR (P = 0.34). PERCUT showed little to no increase in all bronchoscopic techniques, with uncertain evidence (P = 0.02). CONCLUSION: No biopsy method is definitively superior to others. The preferred approach must con sider availability, accessibility, and cost, as safety and diagnostic yield do not differ. Further RCTs planned, conducted, and reported with methodological rigor and transparency are needed, and additional studies should assess cost and the correlation between nodule size and location, as well as their association with biopsy results.
URI: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2069
ISSN: 1806-9460
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.